A Win For Can-Fite BioPharma Ltd.
Wed, Jul 01, 2026 at 07:07 PM
Can-Fite BioPharma Ltd. (CANF:NYSEMKT) jumped higher at $4.63, a gain of 55.9%. On Wed, Jul 01, 2026, CANF:NYSEMKT hit a New 2-Week High of $4.63. The stock appeared on our News Catalysts scanner on Wed, Jul 01, 2026 at 08:02 AM in the 'BIOTECH' category. From Wed, Jun 17, 2026, the stock recorded 44.44% Up Days and 40.00% Green Days
The stock spiked on Wed, Jul 01, 2026 at $5.98 with a volume of 57M+.
About Can-Fite BioPharma Ltd. (CANF:NYSEMKT)
Can Fite Biofarma Ltd is a clinical stage biopharmaceutical company. It develops orally bioavailable small molecule therapeutic products for the treatment of autoimmune-inflammatory, oncological and ophthalmic diseases.
Top 10 Gainers:
- Linkhome Holdings Inc. (LHAI:NASDAQ), 315.15%
- Token Cat Limited (TC:NASDAQ), 159.46%
- Eason Technology Limited (DXF:NYSEMKT), 140.56%
- Sadot Group Inc. (SDOT:NASDAQ), 105.19%
- Eshallgo Inc. (EHGO:NASDAQ), 104.62%
- Can-Fite BioPharma Ltd. (CANF:NYSEMKT), 55.89%
- Sable Offshore Corp. (SOC:NYSE), 42.86%
- DSC Holdings Ltd. (DSC:NASDAQ), 39.67%
- Sol Strategies Inc. (STKE:NASDAQ), 36.75%
- UTime Limited (WTO:NASDAQ), 34.45%